Trial Profile
Randomized, placebo-controlled, double-blind evaluation of the safety and pharmacokinetics of multiple doses of BI 1060469 in healthy, fed female volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Nov 2016
Price :
$35
*
At a glance
- Drugs BI 1060469 (Primary)
- Indications Asthma
- Focus Adverse reactions
- 18 Nov 2016 New trial record